As of 10:30 AM on the 15th, United Pharm is trading at 25,650 KRW, down 2.29% from the previous day. This represents a 15.49% decrease compared to July 6. United Pharm is known as a specialized pharmaceutical manufacturing and sales company.
Over the past 5 days, individual investors have net purchased 141,035 shares, while foreigners and institutions have net sold 105,168 shares and 46,025 shares, respectively.
On July 10, United Pharm became a market topic with the news of a US patent for the next-generation liver treatment 'Oranopin' causing a 'rise'.
※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
